Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Vera Therapeutics, Inc. | 42,403 | reported | 23 Mar 2026 | tx 2+99,253 |
| Vaxcyte, Inc. | 5,625 | reported | 16 Aug 2021 | tx 17+113,340−40,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 23 Mar 2026 | GRANT_AWARD | Vera Therapeutics, Inc. | 42,403 | 0.00 USD | |
| 23 Mar 2026 | GRANT_AWARD | Vera Therapeutics, Inc. | 56,850 | 0.00 USD | deriv |
| 16 Aug 2021 | SALE | Vaxcyte, Inc. | 2,500 | 26.00 USD | |
| 16 Aug 2021 | EXERCISE | Vaxcyte, Inc. | 2,500 | 2.03 USD | |
| 16 Aug 2021 | EXERCISE | Vaxcyte, Inc. | 2,500 | 0.00 USD | deriv |
| 12 Aug 2021 | EXERCISE | Vaxcyte, Inc. | 10,000 | 2.03 USD | |
| 12 Aug 2021 | SALE | Vaxcyte, Inc. | 10,000 | 26.00 USD | |
| 12 Aug 2021 | EXERCISE | Vaxcyte, Inc. | 10,000 | 0.00 USD | deriv |
| 01 Apr 2021 | GRANT_AWARD | Vaxcyte, Inc. | 93,340 | 0.00 USD | deriv |
| 15 Mar 2021 | SALE | Vaxcyte, Inc. | 1,487 | 27.49 USD | |
| 15 Mar 2021 | EXERCISE | Vaxcyte, Inc. | 2,500 | 2.03 USD | |
| 15 Mar 2021 | SALE | Vaxcyte, Inc. | 1,013 | 27.01 USD | |
| 15 Mar 2021 | EXERCISE | Vaxcyte, Inc. | 2,500 | 0.00 USD | deriv |
| 16 Feb 2021 | SALE | Vaxcyte, Inc. | 2,500 | 26.95 USD | |
| 16 Feb 2021 | EXERCISE | Vaxcyte, Inc. | 2,500 | 2.03 USD | |
| 16 Feb 2021 | EXERCISE | Vaxcyte, Inc. | 2,500 | 0.00 USD | deriv |
| 15 Jan 2021 | SALE | Vaxcyte, Inc. | 2,500 | 26.00 USD | |
| 15 Jan 2021 | EXERCISE | Vaxcyte, Inc. | 2,500 | 2.03 USD | |
| 15 Jan 2021 | EXERCISE | Vaxcyte, Inc. | 2,500 | 0.00 USD | deriv |